Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin.

Buraschi S, Xu SQ, Stefanello M, Moskalev I, Morcavallo A, Genua M, Tanimoto R, Birbe R, Peiper SC, Gomella LG, Belfiore A, Black PC, Iozzo RV, Morrione A.

Oncotarget. 2016 May 23. doi: 10.18632/oncotarget.9556. [Epub ahead of print]

2.

Radiographic Kinetics of Sarcomatoid Renal Cell Carcinoma.

Syed A, Raval A, Pridjian A, Birbe R, Trabulsi EJ.

Urology. 2016 Jul;93:e13-4. doi: 10.1016/j.urology.2016.03.027. Epub 2016 Mar 31.

PMID:
27041470
3.

Multicompartment metabolism in papillary thyroid cancer.

Curry JM, Tassone P, Cotzia P, Sprandio J, Luginbuhl A, Cognetti DM, Mollaee M, Domingo-Vidal M, Pribitkin EA, Keane WM, Zhan T, Birbe R, Tuluc M, Martinez-Outschoorn U.

Laryngoscope. 2016 Oct;126(10):2410-8. doi: 10.1002/lary.25799. Epub 2015 Dec 15.

PMID:
26666958
4.

Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer.

Johnson JM, Lai SY, Cotzia P, Cognetti D, Luginbuhl A, Pribitkin EA, Zhan T, Mollaee M, Domingo-Vidal M, Chen Y, Campling B, Bar-Ad V, Birbe R, Tuluc M, Martinez Outschoorn U, Curry J.

Semin Oncol. 2015 Dec;42(6):915-22. doi: 10.1053/j.seminoncol.2015.09.025. Epub 2015 Sep 24.

5.

Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates.

Mills TA, Orloff M, Domingo-Vidal M, Cotzia P, Birbe RC, Draganova-Tacheva R, Martinez Cantarin MP, Tuluc M, Martinez-Outschoorn U.

Semin Oncol. 2015 Dec;42(6):909-14. doi: 10.1053/j.seminoncol.2015.09.006. Epub 2015 Sep 8.

PMID:
26615135
6.

VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man.

Tripathi S, Trabulsi EJ, Gomella L, Kim S, McCue P, Intenzo C, Birbe R, Gandhe A, Kumar P, Thakur M.

Urology. 2016 Feb;88:111-8. doi: 10.1016/j.urology.2015.10.012. Epub 2015 Oct 28.

PMID:
26519886
7.

DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.

Goodwin JF, Kothari V, Drake JM, Zhao S, Dylgjeri E, Dean JL, Schiewer MJ, McNair C, Jones JK, Aytes A, Magee MS, Snook AE, Zhu Z, Den RB, Birbe RC, Gomella LG, Graham NA, Vashisht AA, Wohlschlegel JA, Graeber TG, Karnes RJ, Takhar M, Davicioni E, Tomlins SA, Abate-Shen C, Sharifi N, Witte ON, Feng FY, Knudsen KE.

Cancer Cell. 2015 Jul 13;28(1):97-113. doi: 10.1016/j.ccell.2015.06.004.

8.

A novel role for drebrin in regulating progranulin bioactivity in bladder cancer.

Xu SQ, Buraschi S, Morcavallo A, Genua M, Shirao T, Peiper SC, Gomella LG, Birbe R, Belfiore A, Iozzo RV, Morrione A.

Oncotarget. 2015 May 10;6(13):10825-39.

9.

Predictors of positive surgical margins after radical prostatectomy at a single institution: preoperative and pathologic factors, and the impact of surgeon variability and technique on incidence and location.

Lallas CD, Fashola Y, Den RB, Gelpi-Hammerschmidt F, Calvaresi AE, McCue P, Birbe R, Gomella LG, Trabulsi EJ.

Can J Urol. 2014 Oct;21(5):7479-86.

PMID:
25347375
10.

The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness.

Thangavel C, Boopathi E, Ciment S, Liu Y, O' Neill R, Sharma A, McMahon SB, Mellert H, Addya S, Ertel A, Birbe R, Fortina P, Dicker AP, Knudsen KE, Den RB.

Clin Cancer Res. 2014 Nov 1;20(21):5468-82. doi: 10.1158/1078-0432.CCR-14-0326. Epub 2014 Aug 27.

11.

Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy.

Den RB, Feng FY, Showalter TN, Mishra MV, Trabulsi EJ, Lallas CD, Gomella LG, Kelly WK, Birbe RC, McCue PA, Ghadessi M, Yousefi K, Davicioni E, Knudsen KE, Dicker AP.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1038-46. doi: 10.1016/j.ijrobp.2014.04.052. Epub 2014 Jul 8.

12.

Integrin αvβ6 promotes an osteolytic program in cancer cells by upregulating MMP2.

Dutta A, Li J, Lu H, Akech J, Pratap J, Wang T, Zerlanko BJ, FitzGerald TJ, Jiang Z, Birbe R, Wixted J, Violette SM, Stein JL, Stein GS, Lian JB, Languino LR.

Cancer Res. 2014 Mar 1;74(5):1598-608. doi: 10.1158/0008-5472.CAN-13-1796. Epub 2014 Jan 2.

13.

USP22 regulates oncogenic signaling pathways to drive lethal cancer progression.

Schrecengost RS, Dean JL, Goodwin JF, Schiewer MJ, Urban MW, Stanek TJ, Sussman RT, Hicks JL, Birbe RC, Draganova-Tacheva RA, Visakorpi T, DeMarzo AM, McMahon SB, Knudsen KE.

Cancer Res. 2014 Jan 1;74(1):272-86. doi: 10.1158/0008-5472.CAN-13-1954. Epub 2013 Nov 6.

14.

Renal tumors: diagnostic and prognostic biomarkers.

Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, Shen SS, Grignon DJ, Montironi R, Egevad L, Srigley JR, Delahunt B, Moch H; ISUP Renal Tumor Panel.

Am J Surg Pathol. 2013 Oct;37(10):1518-31. doi: 10.1097/PAS.0b013e318299f12e.

15.

Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations.

Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A, Samaratunga H, Tamboli P, Delahunt B, Egevad L, Montironi R, Srigley JR; members of the ISUP Renal Tumor Panel.

Am J Surg Pathol. 2013 Oct;37(10):1505-17. doi: 10.1097/PAS.0b013e31829a85d0.

PMID:
24025521
16.

The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.

Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F, Moch H, Grignon DJ, Montironi R, Srigley JR; Members of the ISUP Renal Tumor Panel.

Am J Surg Pathol. 2013 Oct;37(10):1490-504. doi: 10.1097/PAS.0b013e318299f0fb.

PMID:
24025520
17.

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.

Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, Zhou M, Argani P; ISUP Renal Tumor Panel.

Am J Surg Pathol. 2013 Oct;37(10):1469-89. doi: 10.1097/PAS.0b013e318299f2d1.

PMID:
24025519
18.

Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.

Martinez-Outschoorn UE, Curry JM, Ko YH, Lin Z, Tuluc M, Cognetti D, Birbe RC, Pribitkin E, Bombonati A, Pestell RG, Howell A, Sotgia F, Lisanti MP.

Cell Cycle. 2013 Aug 15;12(16):2580-97. doi: 10.4161/cc.25510. Epub 2013 Jul 8.

19.

Molecular diagnosis of prostate cancer: are we up to age?

Bhavsar T, McCue P, Birbe R.

Semin Oncol. 2013 Jun;40(3):259-75. doi: 10.1053/j.seminoncol.2013.04.002. Review.

PMID:
23806492
20.

The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens.

Draganova-Tacheva R, Bibbo M, Birbe R, Daskalakis C, Solomides C.

Acta Cytol. 2013;57(3):291-5. doi: 10.1159/000350885. Epub 2013 Apr 25.

PMID:
23635399
Items per page

Supplemental Content

Loading ...
Write to the Help Desk